Biomerica (BMRA) Short Interest Ratio & Short Volume $3.61 +0.01 (+0.28%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$3.58 -0.03 (-0.97%) As of 05/2/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Biomerica Short Interest DataBiomerica (BMRA) has a short interest of 16,400 shares, representing 0.72% of the float (the number of shares available for trading by the public). This marks a -91.18% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 277,254 shares to cover all short positions.Current Short Interest16,400 sharesPrevious Short Interest186,000 sharesChange Vs. Previous Month-91.18%Dollar Volume Sold Short$74,770.88Short Interest Ratio0.2 Days to CoverLast Record DateApril 15, 2025Outstanding Shares2,546,000 sharesFloat Size2,270,000 sharesShort Percent of Float0.72%Today's Trading Volume7,068 sharesAverage Trading Volume277,254 sharesToday's Volume Vs. Average3% Short Selling Biomerica? Sign up to receive the latest short interest report for Biomerica and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBMRA Short Interest Over TimeBMRA Days to Cover Over TimeBMRA Percentage of Float Shorted Over Time Biomerica Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202516,400 shares $74,770.88 -91.2%0.7%0.2 $4.56 3/31/2025186,000 shares $105,462.00 +274.3%1.2%0 $0.57 3/15/202549,700 shares $30,888.55 -65.5%0.3%0 $0.62 2/28/2025143,900 shares $105,752.11 -65.7%0.9%0 $0.73 2/15/2025419,000 shares $347,770.00 +64.6%2.7%0.1 $0.83 1/31/2025254,500 shares $128,497.05 -7.6%N/A0 $0.50 1/15/2025275,500 shares $96,425.00 -24.3%N/A0 $0.35 12/31/2024364,100 shares $109,266.41 -53.5%N/A0.4 $0.30 12/15/2024782,800 shares $245,642.64 -45.3%N/A0.9 $0.31 11/30/20241,430,000 shares $556,985.00 +284.7%N/A1.7 $0.39 Get the Latest News and Ratings for BMRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biomerica and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024371,700 shares $129,760.47 -33.9%N/A0.8 $0.35 10/31/2024562,400 shares $209,212.80 +50.5%N/A1.3 $0.37 10/15/2024373,700 shares $119,995.07 -14.9%N/A1 $0.32 9/30/2024439,000 shares $143,816.40 -22.1%N/A1.2 $0.33 9/15/2024563,400 shares $170,710.20 +582.1%N/A1.5 $0.30 8/31/202482,600 shares $36,344.00 +58.2%N/A0.2 $0.44 8/15/202452,200 shares $16,234.20 -27.5%N/A0.7 $0.31 7/31/202472,000 shares $23,825.52 -14.3%N/A0.9 $0.33 7/15/202484,000 shares $30,063.60 +8.7%N/A0.4 $0.36 6/30/202477,300 shares $33,996.54 -54.4%N/A0.3 $0.44 6/15/2024169,500 shares $97,801.50 -3.3%N/A0.7 $0.58 5/31/2024175,200 shares $101,721.12 -49.0%N/A0.8 $0.58 5/15/2024343,400 shares $209,130.60 +219.7%N/A1.5 $0.61 4/30/2024107,400 shares $64,010.40 +63.2%N/A0.5 $0.60 4/15/202465,800 shares $50,666.00 -1.1%N/A1 $0.77 3/31/202466,500 shares $55,328.00 -13.3%N/A1.1 $0.83 3/15/202476,700 shares $81,302.00 -42.6%N/A0.7 $1.06 2/29/2024133,500 shares $162,870.00 -6.8%N/A0.1 $1.22 2/15/2024143,300 shares $138,599.76 +3.2%N/A0.1 $0.97 1/31/2024138,800 shares $129,084.00 -24.1%N/A0.1 $0.93 1/15/2024182,900 shares $171,487.04 -36.0%N/A0.2 $0.94 12/31/2023285,700 shares $357,125.00 -19.4%N/A0.2 $1.25 12/15/2023354,400 shares $350,856.00 -6.8%N/A0.3 $0.99 11/30/2023380,200 shares $353,586.00 +5.6%N/A6.9 $0.93 11/15/2023360,100 shares $313,719.12 -13.0%N/A6.7 $0.87 10/31/2023414,100 shares $405,818.00 +10.3%N/A6.8 $0.98 10/15/2023375,300 shares $278,097.30 -13.4%N/A1.6 $0.74 9/30/2023433,200 shares $372,638.64 -2.2%N/A1.9 $0.86 9/15/2023442,800 shares $487,080.00 -7.1%N/A2 $1.10 8/31/2023476,400 shares $609,792.00 -11.4%N/A2.1 $1.28Altucher: Turn $900 into $108,000 in just 12 months? (Ad)We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.If I’m right about this (like I was before) a modest $900 investment… 8/15/2023537,800 shares $603,142.70 +56.0%N/A2.3 $1.12 7/31/2023344,700 shares $455,004.00 -3.6%N/A1.5 $1.32 7/15/2023357,600 shares $518,520.00 -3.8%N/A7.7 $1.45 6/30/2023371,600 shares $505,376.00 +12.4%N/A7.9 $1.36 6/15/2023330,600 shares $548,796.00 +2.0%N/A7 $1.66 5/31/2023324,100 shares $444,017.00 +3.8%N/A8.2 $1.37 5/15/2023312,300 shares $390,375.00 -9.0%N/A6.7 $1.25 4/30/2023343,000 shares $456,190.00 -14.8%N/A8.3 $1.33 4/15/2023402,500 shares $675,797.50 -5.4%N/A10.8 $1.68 3/31/2023425,300 shares $795,311.00 -3.9%N/A11.6 $1.87 3/15/2023442,500 shares $1.00 million -0.4%N/A12.1 $2.26 2/28/2023444,400 shares $1.20 million -1.3%3.6%12.9 $2.70 2/15/2023450,400 shares $1.33 million +8.9%3.7%16.5 $2.95 1/31/2023413,600 shares $1.24 million +4.1%3.4%15.3 $3.00 1/15/2023397,200 shares $1.19 million -8.1%3.5%14.2 $3.00 12/30/2022432,300 shares $1.45 million -0.3%3.8%5.7 $3.35 12/15/2022433,700 shares $1.53 million -7.4%3.8%5.1 $3.52 11/30/2022468,500 shares $1.63 million -6.0%4.1%5.3 $3.48 11/15/2022498,200 shares $1.65 million -2.3%4.4%5.3 $3.32 10/31/2022509,700 shares $1.68 million +31.6%4.5%5.2 $3.29 10/15/2022387,400 shares $1.43 million +10.4%3.4%3.7 $3.70 9/30/2022351,000 shares $1.38 million +8.2%3.1%1.1 $3.93 9/15/2022324,300 shares $1.23 million -11.9%2.9%1.1 $3.78 8/31/2022367,900 shares $1.30 million -8.1%3.3%1.2 $3.54 8/15/2022400,200 shares $1.27 million -12.2%3.7%1.4 $3.17 7/31/2022455,700 shares $1.26 million +46.7%4.3%1.6 $2.77 7/15/2022310,700 shares $904,137.00 -0.8%2.9%1.1 $2.91 6/30/2022313,300 shares $905,437.00 -3.0%2.9%11.8 $2.89 6/15/2022323,000 shares $969,000.00 -6.1%4.9%12.3 $3.00 5/31/2022343,800 shares $1.20 million -3.3%3.2%11.5 $3.50 5/15/2022355,600 shares $1.07 million -15.0%3.3%9.3 $3.01 4/30/2022418,200 shares $1.64 million -6.3%3.9%9.6 $3.93 4/15/2022446,300 shares $1.99 million -6.1%4.2%8.6 $4.47 3/31/2022475,200 shares $2.12 million +1.9%4.4%7.1 $4.47 3/15/2022466,200 shares $1.69 million -10.4%4.4%5.7 $3.62 2/28/2022520,100 shares $2.26 million -8.5%4.9%4 $4.34 2/15/2022568,400 shares $2.52 million -34.9%5.3%4.1 $4.44 1/31/2022872,600 shares $3.72 million -8.3%8.2%4.7 $4.26 1/15/2022951,800 shares $4.18 million +1.2%8.9%4.6 $4.39 12/31/2021941,000 shares $3.66 million +18.0%9.1%3.3 $3.89 12/15/2021797,700 shares $3.24 million -0.3%7.7%0.4 $4.06 11/30/2021800,300 shares $3.88 million -32.2%7.7%0.4 $4.85 11/15/20211,180,000 shares $5.55 million +10.3%11.4%0.6 $4.70 10/29/20211,070,000 shares $4.91 million -18.9%10.3%0.5 $4.59 10/15/20211,320,000 shares $7.31 million +66.2%12.7%0.7 $5.54 9/30/2021794,300 shares $3.57 million -18.5%7.6%0.4 $4.50 9/15/2021974,500 shares $4.01 million -11.4%9.4%8 $4.12 8/31/20211,100,000 shares $4.93 million -1.8%10.6%6.8 $4.48 8/13/20211,120,000 shares $4.55 million No Change11.0%6.6 $4.06 7/30/20211,120,000 shares $4.20 million +13.5%11.0%3.5 $3.75Altucher: Turn $900 into $108,000 in just 12 months? (Ad)We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.If I’m right about this (like I was before) a modest $900 investment… 7/15/2021986,900 shares $3.51 million +3.5%9.7%3.2 $3.56 6/30/2021953,400 shares $3.82 million -0.5%9.3%3.3 $4.01 6/15/2021958,200 shares $3.89 million +15.7%9.4%3.2 $4.06 5/28/2021828,100 shares $3.02 million -16.1%8.1%2.8 $3.65 5/14/2021986,600 shares $3.55 million -1.2%N/A3.7 $3.60 4/30/2021998,300 shares $4.69 million -2.1%N/A4.8 $4.70 4/15/20211,020,000 shares $5.21 million +11.0%N/A5.9 $5.11 3/31/2021919,200 shares $4.82 million -10.8%9.5%2.3 $5.24 3/15/20211,030,000 shares $6.20 million -8.9%10.7%2.7 $6.02 2/26/20211,130,000 shares $7.09 million -3.4%11.7%2.9 $6.27 2/12/20211,170,000 shares $8.89 million -7.9%12.1%3 $7.60 1/29/20211,270,000 shares $8.53 million +31.0%13.2%3.2 $6.72 1/15/2021969,200 shares $5.87 million +34.9%10.0%2.6 $6.06 12/31/2020718,300 shares $3.51 million -6.7%7.9%2.1 $4.88 12/15/2020769,500 shares $4.39 million -3.7%8.5%5.6 $5.71 11/30/2020799,300 shares $5.39 million +15.5%8.8%5.5 $6.74 11/15/2020692,100 shares $4.65 million +2.5%7.7%3.8 $6.72 10/30/2020675,000 shares $3.77 million +3.4%7.5%2.6 $5.59 10/15/2020653,000 shares $5.07 million -1.9%7.2%2 $7.76 9/30/2020665,300 shares $4.61 million -17.5%7.4%1.2 $6.93 9/15/2020806,300 shares $5.59 million +9.2%8.9%1.3 $6.93 8/31/2020738,300 shares $5.36 million +11.3%8.2%0.9 $7.26 8/14/2020663,200 shares $5.45 million +26.8%7.3%0.8 $8.22 7/31/2020523,200 shares $4.77 million -11.0%5.8%0.7 $9.11 7/15/2020587,700 shares $5.62 million +19.5%6.6%0.7 $9.56 6/30/2020491,800 shares $3.57 million +87.2%5.7%0.6 $7.25 6/15/2020262,700 shares $1.43 million +109.5%3.1%0.3 $5.46 5/29/2020125,400 shares $812,592.00 +10.4%1.5%0.1 $6.48 5/15/2020113,600 shares $840,640.00 -45.8%1.3%0.1 $7.40 BMRA Short Interest - Frequently Asked Questions What is Biomerica's current short interest? Short interest is the volume of Biomerica shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 16,400 shares of BMRA short. 0.72% of Biomerica's shares are currently sold short. Learn More on Biomerica's current short interest. Which institutional investors are shorting Biomerica? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Biomerica: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Biomerica? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.72% of Biomerica's floating shares are currently sold short. Is Biomerica's short interest increasing or decreasing? Biomerica saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 16,400 shares, a decrease of 91.2% from the previous total of 186,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Biomerica's float size? Biomerica currently has issued a total of 2,546,000 shares. Some of Biomerica's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Biomerica currently has a public float of 2,270,000 shares. How does Biomerica's short interest compare to its competitors? 0.72% of Biomerica's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Biomerica: Shattuck Labs, Inc. (4.14%), Werewolf Therapeutics, Inc. (6.82%), SCYNEXIS, Inc. (1.88%), Estrella Immunopharma, Inc. (0.02%), Celularity Inc. (12.53%), Akari Therapeutics, Plc (0.29%), Lantern Pharma Inc. (3.40%), Aadi Bioscience, Inc. (6.58%), NRx Pharmaceuticals, Inc. (8.84%), RenovoRx, Inc. (0.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Biomerica stock? Short selling BMRA is an investing strategy that aims to generate trading profit from Biomerica as its price is falling. BMRA shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biomerica? A short squeeze for Biomerica occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BMRA, which in turn drives the price of the stock up even further. How often is Biomerica's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMRA, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies STTK Short Squeeze HOWL Short Squeeze SCYX Short Squeeze ESLA Short Squeeze CELU Short Squeeze AKTX Short Squeeze LTRN Short Squeeze AADI Short Squeeze NRXP Short Squeeze RNXT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BMRA) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomerica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomerica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BMRA Stock Free BMRA Stock Alerts